Septerna (SEPN) announced its decision to discontinue the Phase 1 single- and multiple-ascending dose clinical trial of SEP-786 in healthy ...
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
Will Smith has a couple of eerie coincidences that he doesn’t like talking about too much.
Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...
Political uncertainty in some of the largest European economies has diminished their growth outlook. Read more here.
15h
GameRant on MSNBest Survivors In Dead By DaylightEach one of Dead by Daylight's Survivors has unique Perks that give them an edge against the Killers, but some are better than others.
21h
GlobalData on MSNFDA grants fast track status to Rznomics’ RZ-001 for HCCThe US Food and Drug Administration (FDA) has granted fast track designation to Rznomics' RZ-001 for the treatment of ...
An Australian medical cannabis company is set to open a new UK operation in Birmingham. Sydney-based Cannim has struck a deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results